FDA to speed up approvals of generic biologic medicines as Trump targets high drug costs by CNBC Markets | October 30, 2025 1:06 am | US Markets It’s the Trump administration’s latest move to rein in high prescription drug costs in the U.S., and could be a blow to pharmaceutical companies.
